吸烟、呼吸道症状、肺功能与预期寿命:一项老龄化纵向研究
基于2004/05年英格兰老龄化纵向研究(ELSA)8930名≥50岁参与者及截至2012年死亡数据,采用参数生存模型分析吸烟、慢性咳痰、气短(SOB)及FEV1/FVC与剩余预期寿命(LE)的关联。结果显示症状和FEV1/FVC对剩余LE的预测差异因吸烟状态而异;50岁男性当前吸烟者伴SOB且FEV1/FVC<0.70的剩余LE为19.2年(95%CI:16.5-22.2),较参照组减少8.1年(95%CI:5.3-10.8)。
要点
- 吸烟、呼吸道症状和FEV1/FVC与老年人剩余预期寿命强烈相关。
- 症状和FEV1/FVC对剩余LE的预测差异因吸烟状态而异。
- 50岁男性当前吸烟者伴SOB且FEV1/FVC<0.70的剩余LE减少8.1年。
核心结论
- 吸烟、呼吸道症状和FEV1/FVC与老年人剩余预期寿命强烈相关。
研究设计与样本
- 数据来自2004/05年英格兰老龄化纵向研究(ELSA),纳入8930名≥50岁参与者,死亡数据截至2012年。
- 采用参数生存函数估计吸烟、呼吸道症状及FEV1/FVC与剩余LE的关联,并调整基线年龄和性别等协变量。
主要发现
- 症状和FEV1/FVC对剩余LE的预测差异因吸烟状态而异。
- 在从不吸烟者中,仅气短(SOB)者剩余LE较参照组显著降低。
- 在既往和当前吸烟者中,有呼吸道症状且FEV1/FVC<0.70者剩余LE较参照组显著降低,而FEV1/FVC≥0.70者无此显著降低。
- 50岁男性当前吸烟者伴SOB且FEV1/FVC<0.70的剩余LE为19.2年(95%CI:16.5-22.2),较参照组减少8.1年(95%CI:5.3-10.8)。
临床怎么用
- 可利用吸烟状态、呼吸道症状和FEV1/FVC识别剩余预期寿命降低的老年人。
- 用剩余预期寿命向患者传达死亡风险需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Prognostic indices have been developed to predict various outcomes, including mortality. These indices and hazard ratios may be difficult for patients to understand. We investigated the association between smoking, respiratory symptoms and lung function with remaining life expectancy (LE) in older adults. METHODS: Data were from the 2004/05 English Longitudinal Study of Ageing (ELSA) (n = 8930), participants aged ≥50-years, with mortality data until 2012. Respiratory symptoms included were chronic phlegm and shortness of breath (SOB). The association between smoking, respiratory symptoms and FEV1/FVC, and remaining LE was estimated using a parametric survival function and adjusted for covariates including age at baseline and sex. RESULTS: The extent to which symptoms and FEV1/FVC predicted differences in remaining LE varied by smoking. Compared to asymptomatic never smokers with normal lung function (the reference group), in never smokers, only those with SOB had a significant reduction in remaining LE. In former and current smokers, those with respiratory symptoms had significantly lower remaining LE compared to the reference group if they had FEV1/FVC <0.70 compared to those with FEV1/FVC ≥0.70. Males aged 50-years, current smokers with SOB and FEV1/FVC <0.70, had a remaining LE of 19.2 (95%CI: 16.5-22.2) years, a decrease of 8.1 (5.3-10.8) years, compared to the reference group. CONCLUSION: Smoking, respiratory symptoms and FEV1/FVC are strongly associated with remaining LE in older people. The use of remaining LE to communicate mortality risk to patients needs further investigation.
引用
- Petrie K, Abramson MJ, George J, et al. Smoking, respiratory symptoms, lung function and life expectancy: A longitudinal study of ageing. Respirology. 2024. PMID: 38403987. doi:10.1111/resp.14683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。